Erol Verter, MD
Ophthalmology · Norwalk, CTNPI 1548610454
Payments from drug & device makers
Across 162 payments — averaging $33.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$1K
- Regeneron Healthcare Solutions, Inc.$905
- AbbVie$642
- Coherus Oncology, Inc.$329
- Genentech USA, Inc.$324
- Alimera Sciences, Inc.$303
- plus $2K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 30 | $1,133 |
| Regeneron Healthcare Solutions, Inc. | 27 | $905 |
| AbbVie(2 entities) | 16 | $642 |
| Coherus Oncology, Inc. | 7 | $329 |
| Genentech USA, Inc. | 18 | $324 |
| Alimera Sciences, Inc. | 17 | $303 |
| Sandoz | 5 | $280 |
| Alcon | 6 | $266 |
| Glaukos Corporation | 4 | $264 |
| Astellas Pharma US Inc | 6 | $236 |
| Genentech, Inc. | 1 | $143 |
| Bausch & Lomb Americas Inc. | 6 | $100 |
| Novartis | 1 | $100 |
| Apellis Pharmaceuticals, Inc. | 3 | $89 |
| Halozyme Inc | 2 | $50 |
| Dutch Ophthalmic, USA | 1 | $49 |
| Johnson & Johnson | 2 | $38 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $36 |
| Ocular Therapeutix, Inc. | 2 | $30 |
| Harrow Eye, LLC | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Omeros Corporation | 1 | $16 |
| Amgen | 1 | $16 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$5,442 in reported general payments places this provider in the 85th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Norwalk
- Scott SpectorNorwalk$23K
- Ding MaNorwalk$5K
- Matthew PaulDanbury$944K
- Amir CohenNew Haven$441K
- John HuangHartford$390K
- James MurphyHamden$176K
- Anthony DanielsNew Haven$66K
- James TalbotNew Canaan$47K
- Paul KangNew Haven$40K
- Anish ShahNorwich$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.